Abbvie Receives Positive Chmp Opinion for Epcoritamab (Tepkinly®) for the Treatment of Adults With Relapsed/Refractory Follicular Lymphoma
艾伯維公司獲歐洲藥品管理局(CHMP)正面意見,用於治療復發/難治性濾泡性淋巴瘤的 Epcoritamab(Tepkinly®)成年人。
Abbvie Receives Positive Chmp Opinion for Epcoritamab (Tepkinly®) for the Treatment of Adults With Relapsed/Refractory Follicular Lymphoma
艾伯維公司獲歐洲藥品管理局(CHMP)正面意見,用於治療復發/難治性濾泡性淋巴瘤的 Epcoritamab(Tepkinly®)成年人。
譯文內容由第三人軟體翻譯。